Publications en collaboration avec des chercheurs de Universidad de Cantabria (8)

2024

  1. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

    Acta Neuropathologica, Vol. 148, Núm. 1

2021

  1. Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge

    British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278

  2. Clinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosis

    British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1257-1268

2020

  1. ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage

    Journal of Neurology, Vol. 267, Núm. 5, pp. 1291-1299

  2. Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis

    Neural Regeneration Research, Vol. 15, Núm. 11, pp. 2043-2044

2019

  1. Amyotrophic lateral sclerosis: A complex syndrome that needs an integrated research approach

    Neural Regeneration Research, Vol. 14, Núm. 2, pp. 193-196

2018

  1. The increasing importance of environmental conditions in amyotrophic lateral sclerosis

    International Journal of Biometeorology, Vol. 62, Núm. 8, pp. 1361-1374

2017

  1. Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain

    Scientific Reports, Vol. 7, Núm. 1